Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate

被引：0
|
作者：
Babameto-Laku, A. [1 ]
Mokin, V. [1 ]
Cikuli, M. [1 ]
Xhumari, P. [2 ,3 ]
机构：
[1] Univ Hosp Ctr, Serv Med Genet, Tirana, Albania
[2] Univ Hosp Ctr, Haematol Serv, Tirana, Albania
[3] Fac Med, Tirana, Albania
来源：
CHROMOSOME RESEARCH | 2005年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [21] Assessment of fibrosis and vascularization of bone marrow stroma of Chronic Myeloid Leukemia patients treated with imatinib mesylate and their relationship with the cytogenetic response
    de Jesus, Caroline Regina
    I-Ching, Lee
    Carvalho Neiva, Teresinha de Jesus
    Vituri, Cidonia de Lourdes
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 47 (02) : 313 - 322
  • [22] Prediction of optimal cytogenetic responses at 6 and 12 months in patients with chronic myeloid leukemia in chronic phase treated with imatinib
    Milosevic, Violeta
    Jovanovic, Maja Perunicic
    Bukumiric, Zoran
    Djordjevic, Vesna
    Jovanovic, Jelica
    Fekete, Marija Dencic
    Lekovic, Danijela
    Bogdanovic, Andrija
    JOURNAL OF BUON, 2021, 26 (03): : 1070 - 1079
  • [23] Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
    Alves, Alexandra Rodrigues
    Lima, William Gustavo
    Nagai, Michelly Martins
    Vilela Rodrigues, Joao Paulo
    Ayres, Lorena Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (04) : 581 - 589
  • [24] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [25] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
    Monique P. Curran
    Katherine F. Croom
    Karen L. Goa
    BioDrugs, 2004, 18 : 207 - 210
  • [26] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [27] Spotlight on imatinib mesylate in chronic myeloid leukemia
    Curran, MP
    Croom, KF
    Goa, KL
    BIODRUGS, 2004, 18 (03) : 207 - 210
  • [28] Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
    Jabbour, Elias
    Kantarjian, Hagop M.
    Jones, Dan
    Shan, Jenny
    O'Brien, Susan
    Reddy, Neeli
    Wierda, William G.
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Rios, Mary Beth
    Cortes, Jorge
    BLOOD, 2009, 113 (10) : 2154 - 2160
  • [29] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [30] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
    Arora, Brijesh
    Kumar, Lalit
    Kumari, Mamta
    Sharma, Atul
    Wadhawa, Jyoti
    Kochupillai, V
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
12345